Aarti Drugs declares Rs 2 interim dividend, posts Q3 FY26 audited results

Results View source PDF Explain this filing

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.0%Reaction day

₹393.40

prior close

₹356.30

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.3%-7.3% vs market

Pharmaceuticals peers, median of 155sector+0.2%-6.2% vs sector

On the reaction day the stock moved 7.3 pts less than Nifty Microcap 250 and 6.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.7

10m

+1.9

15m

+2.0

30m

+2.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.0+1.3-7.3+0.2-6.2

Next day

-4.5+0.3-4.8-0.4-4.2

-4.7-0.5-4.2-1.1-3.6

-4.3+2.1-6.4+0.7-5.0

-4.1+3.1-7.2+1.3-5.4

-4.7+2.6-7.3+1.5-6.1

-5.7+0.6-6.2+0.3-6.0

15d

-5.8-1.4-4.4-2.3-3.6

-8.4-6.9-1.5-5.1-3.3

-9.6-7.7-1.9-7.9-1.7

+0.7+7.0-6.3+0.8-0.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aarti Drugs reported Q3 and 9M FY26 audited results. Board declared interim dividend of Rs 2 per share (20%) on face value of Rs 10, totaling about Rs 18.25 crore. Record date is Feb 9, 2026. Standalone 9M revenue rose to Rs 184.66 crore from Rs 172.48 crore, but PAT fell to Rs 12.43 crore from Rs 14.06 crore. New Sayakha, Gujarat plant started commercial ops on Sep 4, 2025.

Likely market impact

Positive dividend for shareholders, but 9M PAT decline tempers the cheer. Investors will watch Sayakha plant ramp-up and Q4 demand.